• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impaired microcirculation function in COVID-19 and implications for potential therapies.

作者信息

Gąsecka Aleksandra, Filipiak Krzysztof J, Jaguszewski Miłosz J

机构信息

First Chair and Department of Cardiology, Medical University of Warsaw, Poland.

First Department of Cardiology, Medical University of Gdansk, Gdańsk, Poland.

出版信息

Cardiol J. 2020;27(5):485-488. doi: 10.5603/CJ.2020.0154.

DOI:10.5603/CJ.2020.0154
PMID:33165898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8078995/
Abstract
摘要

相似文献

1
Impaired microcirculation function in COVID-19 and implications for potential therapies.新型冠状病毒肺炎中微循环功能受损及其对潜在治疗的意义。
Cardiol J. 2020;27(5):485-488. doi: 10.5603/CJ.2020.0154.
2
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.2019冠状病毒病与心血管系统：影响与启示。
Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.
3
COVID-19 Fatigue: Not So Fast.新冠疲劳：没那么快。
JACC Heart Fail. 2020 Jul;8(7):592-594. doi: 10.1016/j.jchf.2020.06.001. Epub 2020 Jun 4.
4
Towards precision management of cardiovascular patients with COVID-19 to reduce mortality.实现对新冠肺炎心血管疾病患者的精准管理以降低死亡率。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):529-530. doi: 10.1016/j.pcad.2020.04.012. Epub 2020 Apr 28.
5
Coronavirus disease 2019 and cardiovascular implications.新型冠状病毒病 2019 与心血管影响。
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):725-732. doi: 10.2459/JCM.0000000000001068.
6
COVID-19 and the Heart.新型冠状病毒肺炎与心脏
Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7.
7
Could reperfusion pulmonary oedema explain worsening progress in COVID-19 pneumonia?再灌注性肺水肿能解释新冠病毒肺炎病情的恶化进展吗？
Emerg Med J. 2020 Nov;37(11):705-706. doi: 10.1136/emermed-2020-210085. Epub 2020 Sep 28.
8
2019 CORONAVIRUS: What are the implications for cardiology?2019新型冠状病毒：对心脏病学有何影响？
Eur J Prev Cardiol. 2020 May;27(8):793-796. doi: 10.1177/2047487320918102. Epub 2020 Apr 3.
9
COVID-19: an update and cardiac involvement.新型冠状病毒肺炎：最新情况及心脏受累情况
J Cardiothorac Surg. 2020 Sep 9;15(1):239. doi: 10.1186/s13019-020-01299-5.
10
SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart.新型冠状病毒感染与心血管疾病：COVID-19 心脏。
Heart Lung Circ. 2020 Jul;29(7):973-987. doi: 10.1016/j.hlc.2020.05.101. Epub 2020 Jun 5.

引用本文的文献

1
Perioperative cardiovascular risk and preventions of patients with post-COVID-19 condition.新冠后状态患者的围手术期心血管风险及预防措施
Heliyon. 2024 Oct 15;10(20):e39345. doi: 10.1016/j.heliyon.2024.e39345. eCollection 2024 Oct 30.
2
Soluble platelet selectin and platelets in COVID-19: a multifaceted connection.新冠病毒疾病中的可溶性血小板选择素与血小板：多方面的联系
Ann Med Surg (Lond). 2024 Jun 20;86(8):4634-4642. doi: 10.1097/MS9.0000000000002302. eCollection 2024 Aug.
3
Assessment of Blood Microcirculation Changes after COVID-19 Using Wearable Laser Doppler Flowmetry.使用可穿戴式激光多普勒血流仪评估新冠病毒感染后血液微循环变化
Diagnostics (Basel). 2023 Mar 1;13(5):920. doi: 10.3390/diagnostics13050920.
4
TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice.行动时机。意大利-西班牙-波兰-乌兹别克专家论坛立场文件 2022 年版。血脂异常和动脉高血压：临床实践中最重要且可改变的两个危险因素。
Cardiol J. 2022;29(5):730-738. doi: 10.5603/CJ.a2022.0087. Epub 2022 Sep 19.
5
Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients after COVID-19.使用 1-MNA 改善 COVID-19 后患者的运动耐量和疲劳。
Nutrients. 2022 Jul 22;14(15):3004. doi: 10.3390/nu14153004.
6
Impaired skin microvascular endothelial reactivity in critically ill COVID-19 patients.危重症COVID-19患者皮肤微血管内皮反应性受损。
Ann Intensive Care. 2022 Jun 13;12(1):51. doi: 10.1186/s13613-022-01027-3.
7
[Consensus document of the Mexican Society of Cardiology for post-COVID-19 cardiovascular clinical follow-up].[墨西哥心脏病学会关于 COVID-19 后心血管临床随访的共识文件]
Arch Cardiol Mex. 2022 Apr 4;93(Supl 6):115-133. doi: 10.24875/ACM.21000287.
8
Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review.心外膜脂肪组织在心血管疾病中的作用：综述
Biology (Basel). 2022 Feb 23;11(3):355. doi: 10.3390/biology11030355.
9
How to Maintain Safety and Maximize the Efficacy of Cardiopulmonary Resuscitation in COVID-19 Patients: Insights from the Recent Guidelines.如何在新冠肺炎患者中维持心肺复苏的安全性并最大化其疗效：来自最新指南的见解
J Clin Med. 2021 Nov 30;10(23):5667. doi: 10.3390/jcm10235667.
10
Need to update cardiological guidelines to prevent COVID-19 related myocardial infarction and ischemic stroke.需要更新心脏病学指南以预防与 COVID-19 相关的心肌梗死和缺血性中风。
Cardiol J. 2022;29(1):174-175. doi: 10.5603/CJ.a2021.0120. Epub 2021 Oct 13.

本文引用的文献

1
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.新型冠状病毒肺炎肺血管内凝血病变的免疫机制
Lancet Rheumatol. 2020 Jul;2(7):e437-e445. doi: 10.1016/S2665-9913(20)30121-1. Epub 2020 May 7.
2
Ion channel inhibition against COVID-19: A novel target for clinical investigation.针对新型冠状病毒肺炎的离子通道抑制作用：一个临床研究的新靶点
Cardiol J. 2020;27(4):421-424. doi: 10.5603/CJ.a2020.0090. Epub 2020 Jul 9.
3
Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients.心肌损伤的确定可改善 COVID-19 患者的风险分层并预测其死亡率。
Cardiol J. 2020;27(5):489-496. doi: 10.5603/CJ.a2020.0089. Epub 2020 Jun 26.
4
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.非裔美国人 COVID-19 患者的肺部和心脏病理学：来自新奥尔良的尸检系列。
Lancet Respir Med. 2020 Jul;8(7):681-686. doi: 10.1016/S2213-2600(20)30243-5. Epub 2020 May 27.
5
[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].7例重症新型冠状病毒肺炎合并肢端缺血患者的临床及凝血特征
Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):302-307. doi: 10.3760/cma.j.issn.0253-2727.2020.008.
6
Importance of precise data on SARS-CoV-2 transmission dynamics control.关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）传播动力学控制的精确数据的重要性。
Lancet Infect Dis. 2020 Aug;20(8):877-879. doi: 10.1016/S1473-3099(20)30359-5. Epub 2020 May 15.
7
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
8
COVID-19 - Toward a comprehensive understanding of the disease.COVID-19 - 对该疾病的全面认识。
Cardiol J. 2020;27(2):99-114. doi: 10.5603/CJ.a2020.0065. Epub 2020 May 7.
9
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.COVID-19 皮肤表现分类：西班牙 375 例快速前瞻性全国共识研究。
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
10
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.